WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 6 fonti

Takeda’s QDENGA approved in India, can be given despite pre-exposure to dengue

Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention efforts.

Raccontata da

economictimes.indiatimes.com

hindustantimes.com

thehindubusinessline.com

timesofindia.indiatimes.com

asia.nikkei.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo2 g fa

Takeda’s QDENGA approved in India, can be given despite pre-exposure to dengue

Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention efforts.

Timeline cronologica

lunedì 20 luglio 2026·economictimes.indiatimes.com
Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGA
Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA…
lunedì 20 luglio 2026·hindustantimes.com
India gets first dengue vaccine as DCGI approves Takeda’s QDENGA
QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.

1 g fa

QDENGA: India’s first approved dengue vaccine

QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.

Leggi questa versione → originale

economictimes.indiatimes.com2 g fa

Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGA

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA offers protection against all four…

Leggi questa versione → originale

hindustantimes.com2 g fa

India gets first dengue vaccine as DCGI approves Takeda’s QDENGA

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.

Leggi questa versione → originale

timesofindia.indiatimes.com2 g fa

Japanese firm’s dengue vaccine becomes first to get regulatory approval in India

Japanese drug firm Takeda Biopharmaceuticals has received market authorisation from the Drug Controller General of India (DCGI) for QDENGA, making it the first dengue vaccine approved here. The vaccine is designed to…

Leggi questa versione → originale

asia.nikkei.com1 g fa

India approves its first dengue vaccine, from Japan's Takeda

South Asian country grapples with sharp rise in cases over recent years

Leggi questa versione → originale

lunedì 20 luglio 2026·

thehindu.com

India approves first dengue vaccine for individuals aged 4 to 60 years

India approves Takeda's QDENGA dengue vaccine for ages 4-60, offering protection against all virus serotypes without prior screening.

lunedì 20 luglio 2026·

thehindubusinessline.com

Takeda’s QDENGA approved in India, can be given despite pre-exposure to dengue

Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention efforts.

lunedì 20 luglio 2026·

timesofindia.indiatimes.com

Japanese firm’s dengue vaccine becomes first to get regulatory approval in India

Japanese drug firm Takeda Biopharmaceuticals has received market authorisation from the Drug Controller General of India (DCGI) for QDENGA, making it the first dengue vaccine…

martedì 21 luglio 2026·

economictimes.indiatimes.com

Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India

India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027.…

martedì 21 luglio 2026·

thehindu.com

QDENGA: India’s first approved dengue vaccine

QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.

martedì 21 luglio 2026·

asia.nikkei.com

India approves its first dengue vaccine, from Japan's Takeda

South Asian country grapples with sharp rise in cases over recent years

mercoledì 22 luglio 2026·

hindustantimes.com

India gets its first dengue vaccine: Doctors explain who can take it, how it works and whether it's right for you

India has approved its first dengue vaccine. Doctors explain who can get it, how well it works, who should avoid it and why mosquito precautions still matter. | Health